SR One Capital Management Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
260
- Portfolio
-
36
- Exits
-
145
SR One Capital Management General Information
Company Description
Founded in 1985, SR One Capital Management is a venture capital investment firm headquartered in Redwood City, California. The firm seeks to invest in the life science, biotechnology, healthcare, medical devices, and information technology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.srone.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 929 Main Street
- Suite 200
- Redwood City, CA 94063
- United States
SR One Capital Management Investments (260)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Windward Bio | 10-Jan-2025 | Early Stage VC | Drug Discovery | Startup | ||
| Kala Bio | 30-Dec-2024 | Biotechnology | Generating Revenue/Not Profitable | |||
| Antag Therapeutics | 04-Dec-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Vibrant Biomedicines | 01-Nov-2024 | Drug Discovery | Stealth | |||
| Odyssey Therapeutics | 14-Aug-2024 | Biotechnology | Generating Revenue/Not Profitable | |||
| Elektrofi | 08-Aug-2024 | Drug Delivery | Generating Revenue | |||
| Renalys | 17-Jul-2024 | Drug Discovery | Clinical Trials - General | |||
| Asceneuron | 16-Jul-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Kala Bio | 28-Jun-2024 | PIPE | Biotechnology | Generating Revenue/Not Profitable | ||
| Alumis | 29-May-2024 | Later Stage VC | Drug Discovery | Generating Revenue |
SR One Capital Management Exits (145)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Navitor Pharmaceuticals | 25-Oct-2024 | Out of Business | |
| Zenas BioPharma | 13-Sep-2024 | ||
| Morphic Therapeutic | 16-Aug-2024 | ||
| Alumis | 28-Jun-2024 | ||
| Arch Oncology | 31-May-2024 | ||
| Bird Rock Bio | 18-Aug-2023 | ||
| CalciMedica | 21-Mar-2023 | ||
| Mineralys | 09-Feb-2023 | ||
| River 3 Renal | 06-Jan-2023 | Out of Business | |
| ARS Pharmaceuticals | 08-Nov-2022 | Reverse Merger |
SR One Capital Management Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
SR One Capital Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
SR One Capital Management Co-Investors (197)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 8 |
|
|
||
| HBM Healthcare Investments |
|
|
|||
| Novo Holdings |
|
|
|||
| Samsara BioCapital |
|
|
|||
| RA Capital Management |
|
|
SR One Capital Management FAQs
-
What is SR One Capital Management?
Founded in 1985, SR One Capital Management is a venture capital investment firm headquartered in Redwood City, California.
-
When was SR One Capital Management founded?
SR One Capital Management was founded in 2020.
-
Where is SR One Capital Management headquartered?
SR One Capital Management is headquartered in Redwood City, CA.
-
What is SR One Capital Management's total asset value?
SR One Capital Management has around in total assets under management.
-
How many investments has SR One Capital Management made?
SR One Capital Management has made 260 investments.
-
What has SR One Capital Management invested in?
SR One Capital Management has made numerous investments in companies like Windward Bio, Kala Bio, and Antag Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has SR One Capital Management invested in recently?
SR One Capital Management's latest investment was on 10-Jan-2025 in Windward Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
